Target (CBDY) Change in Receivables (2016 - 2026)
Target (CBDY) reported Change in Receivables of $16168.0 for Q1 2026, down 97.16% year-over-year from $569388.0 in Q1 2025, and down 87.22% quarter-over-quarter from $126538.0 in Q4 2025.
Target (CBDY) Change in Receivables (2016 - 2026) Analysis & Trends
Target (CBDY) has 7 years of Change in Receivables data on file, last reported at $16168.0 in Q1 2026.
- Change in Receivables for Q1 2026 came in at $16168.0, down 97.16% year-over-year; the trailing twelve-month figure through Mar 2026 was -$194764.0 (down 133.78% YoY), and the FY2025 annual result was $358456.0, up 139.16% from the prior year.
- Change in Receivables retreated to $16168.0 in Q1 2026 per CBDY's latest filing, from $126538.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $882101.0 in Q4 2023 and troughed at -$922542.0 in Q1 2024.
- A 4-year average of $34131.9 and a median of $28949.0 in 2024 frame the typical range for Change in Receivables.
- On a YoY basis, Change in Receivables climbed as much as 203.23% in 2025 and fell as far as 187.71% in 2025.
- A 4-year view of Change in Receivables shows it stood at $882101.0 in 2023, then tumbled by 95.27% to $41730.0 in 2024, then surged by 203.23% to $126538.0 in 2025, then plunged by 87.22% to $16168.0 in 2026.
- Business Quant data shows CBDY's Change in Receivables at $16168.0 in Q1 2026, $126538.0 in Q4 2025, and $8551.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -78.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 106.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -38.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 81.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 23.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 116.25 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.23 Mn |
| 10 | Target | - | - | 191,787.00 | 16,168.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16,168.00 |
| Mar 31, 2026 | 16,168.00 |
| Dec 31, 2025 | 126,538.00 |
| Dec 31, 2025 | 126,538.00 |
| Sep 30, 2025 | 8,551.00 |
| Sep 30, 2025 | 8,551.00 |
| Jun 30, 2025 | -346,021.00 |
| Jun 30, 2025 | -346,021.00 |
| Mar 31, 2025 | 569,388.00 |
| Mar 31, 2025 | 569,388.00 |
| Dec 31, 2024 | 41,730.00 |
| Dec 31, 2024 | 41,730.00 |
| Sep 30, 2024 | -429,111.00 |
| Sep 30, 2024 | -429,111.00 |
| Jun 30, 2024 | 394,517.00 |
| Jun 30, 2024 | 394,517.00 |
| Mar 31, 2024 | -922,542.00 |
| Mar 31, 2024 | -922,542.00 |
| Dec 31, 2023 | 882,101.00 |
| Dec 31, 2023 | 882,101.00 |